Sharp's first phase of $23 million investment in Bethlehem facility.
Sharp has completed the first phase in the development of its new USD $23m facility in Bethlehem, PA.
Sharp acquired the new Bethlehem facility for $14m in 2017 and has now completed a $2.5m relocation project, transferring the company’s clinical storage and distribution services from its Phoenixville site.
A second phase will see Sharp co-locate its fully integrated clinical services offering at the site when its packaging, manufacturing and analytical services move to the facility in late-2018, following a $6.4 million refit.
The Bethlehem development offers 1.5 million cubic feet of capacity on a 16-acre plot and will allow the company to increase pallet space for both cold and controlled-temperature storage by approximately 50%.
“The Bethlehem facility is a strategically important investment for Sharp. It will allow us to offer greater capacity, scalability and automation in response to growing demand for our services, as well as co-locating our clinical services at one facility,” Frank Lis, president of Sharp Clinical Services, said. “This facility allows us to simultaneously support multiple large-scale phase III studies through to commercial launch.”
Investing in the Bethlehem site- has created 1.5 million cubic feet of new clinical services capacity in 2017 and is consistent with Sharp’s strategy of capacity expansion to support current clients and meet future demand.